SphingoTec Announces Major Management Changes

On March 26, 2024, SphingoTec GmbH, a prominent diagnostic company based in Hennigsdorf, Berlin, unveiled significant alterations to its executive team. Departures include Joerg Menten, CEO, moving into retirement, and Dr. Angelo Moesslang, CFO, concluding his 3-year tenure. SphingoTec heralds the appointment of three internal members: Deborah Bergmann as CEO, Dr. Florian Uhle as CMO, and Nicole Witzmann as CFO.

The Advisory Board’s Chairman, Dr. Gerald Moeller, expressed gratitude towards the outgoing executives for their leadership during pivotal times and for setting a solid groundwork for the company's future direction. Moeller also accoladed the expertise and anticipated contributions of the newly appointed executives towards making SphingoTec a pivotal player in the diagnostics sector, especially in critical care innovations.

Deborah Bergmann, stepping in as CEO, acknowledges the strong foundation left by her predecessors and aims to push SphingoTec’s mission forward, enhancing global patient care and fostering significant clinical and scientific advancements in diagnostics. The newly appointed leaders bring a mixture of clinical, financial, and operational expertise integral for the company's next growth phase.